Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 2, keine Gesamtzahl für „Rilpivirine“
Suchtreffer
Begriffe & Kennungen
Edurant · 4.5 · Medicinal products that affect rilpivirine exposure
Eintrag öffnenEdurant · 4.5 · Medicinal products that are affected by the use of rilpivirine
Eintrag öffnenEdurant · 4.5 · Medicinal products that are affected by the use of rilpivirine
Eintrag öffnenEdurant · 4.5 · Rilpivirine at the recommended dose is not likely to have a clinically relevant effect on the exposure of medi
Eintrag öffnenEdurant · 4.5 · Rilpivirine at the recommended dose is not likely to have a clinically relevant effect on the exposure of medi
Eintrag öffnenEdurant · 4.5 · Rilpivirine is an in vitro inhibitor of the transporter MATE-2K with an IC50 of < 2.7 nM. The clinical implica
Eintrag öffnenEdurant · 4.5 · Rilpivirine is an in vitro inhibitor of the transporter MATE-2K with an IC50 of < 2.7 nM. The clinical implica
Eintrag öffnenEdurant · 4.5 · Rilpivirine is primarily metabolised by cytochrome P450 (CYP)3A. Medicinal products that induce or inhibit CYP
Eintrag öffnenEdurant · 4.5 · Rilpivirine is primarily metabolised by cytochrome P450 (CYP)3A. Medicinal products that induce or inhibit CYP
Eintrag öffnenEdurant · 4.5 · There is limited information available on the potential for a pharmacodynamic interaction between rilpivirine
Eintrag öffnenEdurant · 4.5 · There is limited information available on the potential for a pharmacodynamic interaction between rilpivirine
Eintrag öffnenEdurant · 4.5 · rilpivirine AUC ↑ 49% rilpivirine Cmin ↑ 76% rilpivirine Cmax ↑ 30%
Eintrag öffnenEdurant · 4.5 · rilpivirine AUC ↑ 49% rilpivirine Cmin ↑ 76% rilpivirine Cmax ↑ 30%
Eintrag öffnenEdurant · 4.8 · 33 in the rilpivirine arm and efavirenz arm was 104.3 and 104.1 weeks, respectively. Most ADRs occurred in the
Eintrag öffnenEdurant · 4.8 · 34 Laboratory abnormalities In the rilpivirine arm in the week 96 analysis of the phase 3 ECHO and THRIVE tria
Eintrag öffnenEdurant · 4.8 · 35 The safety and efficacy of rilpivirine in children less than 2 years or weighing less than 14 kg have not b
Eintrag öffnenEdurant · 4.8 · ADRs reported in adult patients treated with rilpivirine are summarised in Table 2. The ADRs are listed by sys
Eintrag öffnenEdurant · 4.8 · ADRs reported in adult patients treated with rilpivirine are summarised in Table 3. The ADRs are listed by sys
Eintrag öffnenEdurant · 4.8 · Laboratory abnormalities In the rilpivirine arm in the week 96 analysis of the phase 3 ECHO and THRIVE trials,
Eintrag öffnenEdurant · 4.8 · The safety and efficacy of rilpivirine in children less than 2 years or weighing less than 14 kg have not been
Eintrag öffnen